期刊文献+

蛋白酪氨酸磷酸酶非受体型22(PTPN-22)基因多态性与青海藏族Graves病的相关性研究 被引量:1

Correlation between gene polymorphism of protein tyrosine-phosphatase, non-receptor type22 and Graves disease in Qinghai Tibetan
原文传递
导出
摘要 目的探讨蛋白酪氨酸磷酸酶非受体型22(PTPN-22)基因多态性与青海藏族Graves病(GD)的关联性。方法选择2012年7月至2016年11月于青海省人民医院门诊及住院部确诊的130例藏族GD患者作为GD组,选择青海省人民医院体检中心查体健康者110例作为对照组:所有调查对象均为无亲缘关系的青海籍藏族世居居民。既往无甲状腺疾病及其他自身免疫性疾病,且无自身免疫性疾病家族史。采用限制性片段长度多态性聚合酶链反应(PCR-RFLP),检测观察对象PTPN-22基因外显子14的1858位C/T基因型及等位基因。结果对照组及GD组行Hardy—Weinberg平衡检验样本代表性,P均〉0.05,提示样本具有群体代表性,可用于群体遗传学研究。对照组与GD组FTPN-22基因外显子14的1858位C/T基因型(CC、CT、TT)频率比较,差异无统计学意义[95.45%(105/110)比93.08%(121/130)、4.55%(5/110)比6.92%(9/130)、O(0/110)比0(0/130),χ^2=0.613,P〉0.05];等位基因(C、T)频率比较,差异无统计学意义[97.73%(215/220)比96.54%(251/260),2.27%(5/220)比3.46%(9/260),χ^2=0.015,P〉0.05]。结论PTPN-22基因外显子14第1858位点C/T基因多态性与青海藏族GD发病无关联性,该基因不是青海藏族GD发病的易感候选基因。 Objective To investigate the correlation between gene polymorphism of protein tyrosine-phosphatase, non-receptor type22 (PTPN-22) and Graves disease (GD) in Qinghai Tibetan. Methods One hundred and thirty Tibetan cases of GD were selected randomly from July 2012 to November 2016 in the People's Hospital of Qinghai Province; meanwhile, 110 normal control cases were selected randomly from the Qinghai Tibetan. All the subjects were non-related Tibetan residents of Qinghai nationality, who had no thyroid disease and other autoimmune diseases, and had no family history of autoimmune diseases. Then genotype and allele of PTPN-22 were detected by the method of polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Results The Hardy-Weinberg balance test was used to examine the representativeness of the control group and the GD group (P 〉 0.05). The suggested samples have population representativeness and can be used in population genetics research. The distribution of PTPN-22 exon 14 (1 858C/T) genotype frequencies (CC, CT, TF) did not differ between normal control cases and GD in Qinghai Tibetan [95.45% (105/110) vs 93.08% (121/130), 4.55% (5/110) vs 6.92% (9/130), 0 (0/110) vs 0 (0/130),χ^2= 0.613, P 〉 0.05]. The distribution of PTPN-22 exon 14 (1 858C/T) allele frequencies (C, T) did not differ between normal control cases and GD in Qinghai Tibetan [97.73%(215/220) vs 96.54% (251/260), 2.27% (5/220) vs 3.46% (9/260),χ^2= 0.015, P 〉 0.05]. Conclusion There is no significant relationship between the polymorphisms of PTPN-22 gene exon 14 (1 858C/T) and GD.
出处 《中华地方病学杂志》 CSCD 北大核心 2017年第9期635-638,共4页 Chinese Journal of Endemiology
基金 青海省科技厅课题(2014-ZJ-769)
关键词 蛋白酪氨酸磷酸酶 基因多态性 GRAVES病 等位基因 Protein tyrosine-phosphatase Gene polymorphism Graves disease Alleles
  • 相关文献

参考文献2

二级参考文献23

  • 1Velaga MR,Wilson V,Jennings CE,et al. The codon 620 tryp-tophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease[J]. Clin Endocrinol Metab, 2004;89(11):5 862-5 865.
  • 2Hill Rj,Zozulya S,Lu YL,et al. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation [J]. Exp Hematol, 2002; 30( 3 ) : 237-244.
  • 3Ladner MB,Bottini N,Valdes AM,et al. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes[J]. Hum Immunol,2005;66( 1 ) :60-64.
  • 4Skorka A,Bednarczuk T,Bar-Andziak E,et al. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population:association and gene dose-dependent correlation with age of onset[J]. Clinical Endocrinology,2005;62(6):679-682.
  • 5Hermann K,Lipponen M,Kiviniemi T,et al. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variantregulates insulin autoimmunity and progression to typel diabetes[J]. Diabetologia,2006; 49(6) : 1 198-1 208.
  • 6Lee YH,Rho YH,Choi SJ,et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis [J]. Rheumatol,2007; 46( 1 ) :49-56.
  • 7Ray D,Tomar N,Gupta N,et al. Protein tyrosine phosphatase non-receptor 22 (PTPN22) gene R620W variant and .sporadic idiopathic hypoparathyroidism in Asian Indians[J]. Immunogenet,2006;33 (4) :237-340.
  • 8Criswell LA,Pfeiffer KA, Lum RF,et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection:the PTPN22 620W allele associates with multiple autoimmune phenotypes[J]. Hum Genet,2005;76(4):561- 571.
  • 9Ban Y,Tozaki T,Taniyama M,et al. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptihility in the Japanese[J]. Thyroid,2005; 15( 10): 1 115-1 118.
  • 10Brix TH, Kyvik KO, Hegedtis L. What is the evidence of genetic factors in the etiology of Graves disease'? A brief review. Thyroid, 1998, 8:627 634.

共引文献6

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部